full issue - Association of Biotechnology and Pharmacy
full issue - Association of Biotechnology and Pharmacy
full issue - Association of Biotechnology and Pharmacy
You also want an ePaper? Increase the reach of your titles
YUMPU automatically turns print PDFs into web optimized ePapers that Google loves.
Current Trends in <strong>Biotechnology</strong> <strong>and</strong> <strong>Pharmacy</strong><br />
Vol. 5 (3) 1251-1272 July 2011, ISSN 0973-8916 (Print), 2230-7303 (Online)<br />
1268<br />
converting enzyme, <strong>and</strong> endothelin<br />
receptors in chronic heart failure.<br />
Circulation, 99: 2118-2123<br />
28. Kawanabe, Y.<strong>and</strong> Nauli, S. (2011).<br />
Endothelin. Cellular <strong>and</strong> Molecular Life<br />
Sciences, 68: 195-203.<br />
29. Schiffrin, E.L. (2001). Role <strong>of</strong> endothelin-<br />
1 in hypertension <strong>and</strong> vascular disease. Am<br />
J Hypertens, 14: 83S-89S<br />
30. Opgenorth, T.J. (1995). Endothelin receptor<br />
antagonism. Adv Pharmacol, 33: 1-65.<br />
31. Nakajima, S., Niiyama, K., Ihara, M.,<br />
Kojiri, K. <strong>and</strong> Suda, H. (1991). Endothelinbinding<br />
inhibitors, BE-18257A <strong>and</strong> BE-<br />
18257B: II. Structure determination. J<br />
Antibiot., 44: 1348-1356.<br />
32. Ihara, M., Fukuroda, T., Saeki, T.,<br />
Nishikibe, M., Kojiri, K., Suda, H. <strong>and</strong><br />
Yano, M. (1991). An endothelin receptor<br />
(ET A<br />
) antagonist isolated from<br />
Streptomyces misakiensis. Biochem<br />
Biophys Res Commun., 178: 132-137.<br />
33. Ishikawa, K., Fukami, T., Nagase, T., Fujita,<br />
K., Hayama, T., Niiyama, K., Mase, T.,<br />
Ihara, M. <strong>and</strong> Yano, M. (1992). Cyclic<br />
pentapeptide endothelin antagonists with<br />
high ET A<br />
selectivity. Potency <strong>and</strong> solubilityenhancing<br />
modifications. J Med Chem., 35:<br />
2139-2142.<br />
34. Zuccarello, M., Lewis, A.I. <strong>and</strong> Rapoport,<br />
R.M. (1994). Endothelin ET A<br />
<strong>and</strong> ET B<br />
receptors in subarachnoid haemorrhageinduced<br />
cerebral vasospasm. Eur J<br />
Pharmacol., 259: R1-R2.<br />
35. Boss, C., Bolli, M. <strong>and</strong> Weller, T. (2002).<br />
Endothelin receptor antagonists: structures,<br />
synthesis, selectivity <strong>and</strong> therapeutic<br />
applications. Current Medicinal Chemistry,<br />
9: 349-383.<br />
36. Mihara, S. <strong>and</strong> Fujimoto, M. (1993). The<br />
endothelin ET A<br />
receptor-specific effect <strong>of</strong><br />
50-235, a nonpeptide endothelin antagonist.<br />
Eur J Pharmacol, 246: 33-38.<br />
37. Zhang, R.L., Zhang, C., Zhang, L., Roberts,<br />
C., Lu, M., Kapke, A., Cui, Y., Ninomiya,<br />
M., Nagafuji, T., Albala, B., Zhang, Z.G.<br />
<strong>and</strong> Chopp, M. (2008). Synergistic effect<br />
<strong>of</strong> an endothelin type A receptor antagonist,<br />
S-0139, with rtPA on the neuroprotection<br />
after embolic stroke. Stroke, 39: 2830-<br />
2836.<br />
38. Elliot, J.D., Lago, M.A., Cousins, R.D.,<br />
Gao, A., Leber, J.D., Erhard, K.F., Nambi,<br />
P., Elshousbaby, N.A., Kumar, C., Lee, J.A.,<br />
Bean, J.W., De Brosse, C.W., Eggleston,<br />
D.S., Brooks, D.P., Beuerstein, G., Ruffolo,<br />
R.R., Weinstock, J., Gleason, J.G., Peish<strong>of</strong>f,<br />
C.E. <strong>and</strong> Ohlstein, E.H. (1994). 1,3-<br />
Diarylindan-2-carboxylic acids, potent <strong>and</strong><br />
selective nonpeptide endothelin receptor<br />
antagonists. J Med Chem., 37: 1553-1557.<br />
39. Clozel, M., Breu, V., Gray, G., Kalina, B.,<br />
L<strong>of</strong>fler, B.M., Burri, K., Cassal, J.M., Hirth,<br />
G., Muller, M., Neidhart, W. <strong>and</strong> Ramuz,<br />
H. (1994). Pharmacological<br />
characterization <strong>of</strong> bosentan, a new potent<br />
orally active nonpeptide endothelin<br />
receptor antagonist. J Pharmacol Exp.<br />
Ther., 270: 228-235.<br />
40. Clozel, M., Breu, V., Burri, K., Cassal, J.M.,<br />
Fischli, W., Gray, G.A., Hirth, G., L<strong>of</strong>fler,<br />
B.M., Muller, M., Neidhart, W. <strong>and</strong> Ramuz,<br />
H. (1993). Pathophysiological role <strong>of</strong><br />
endothelin revealed by the first orally active<br />
endothelin receptor antagonist. Nature,<br />
365: 759-761.<br />
41. Clozel, M., Breu, V., Gray, G.A. <strong>and</strong> L<strong>of</strong>fler,<br />
B.M. (1993). In vivo pharmacology <strong>of</strong> Ro<br />
46-2005, the first synthetic nonpeptide<br />
Does nature has the cure for hypertension